| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8233745 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 7 Pages |
Abstract
I-125 brachytherapy alone achieved excellent rates of medium-term biochemical control in both low- and selected intermediate-risk localized prostate cancer patients. Postimplant dosimetry improved with experience and longer follow-up, confirming the relationship of D90 with biochemical control.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Ann M. M.D., Bashar Ph.D., Kathy R.G.N., Peter M.Sc., Jonathan F.R.C.R., Brendan F.R.C.R., David F.R.C.R., Dan F.R.C.R.,